Inmaculada
Inmaculada Alonso Hernandez US
Patent application number | Description | Published |
---|---|---|
20120294684 | MACHINE TOOL - Machining tool to perform machining processes in the field, comprising a magnetic drill ( | 11-22-2012 |
Inmaculada Alonso Hernandez, Zamudio ES
Patent application number | Description | Published |
---|---|---|
20150044011 | APPARATUS, SYSTEM AND METHOD FOR WIND TURBINE COMPONENT REPLACEMENT - A system, apparatus and method for wind turbine component replacement. The method may include coupling a spreader to a wind turbine component, raising a hoist into the nacelle, raising a spool of cable into a nacelle of the wind turbine, mounting the hoist on a member of the nacelle, routing the cable from the spool of cable to the hoist, and routing the cable between at least one sheave disposed on the hoist and at least one sheave disposed on the spreader. The system may include a spreader, the spreader adapted to couple to a wind turbine component, the spreader including at least one longitudinal member, a pair of transverse members, and at least one first sheave, and a hoist, the hoist adapted to couple to a member of the nacelle, the hoist including a frame, a motor, and at least one second sheave. | 02-12-2015 |
Inmaculada Campins, Mataro (barcelona) ES
Patent application number | Description | Published |
---|---|---|
20090306128 | PHARMACEUTICAL COMPOSITIONS CONTAINING A FLUOROQUINOLONE ANTIBIOTIC DRUG - Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions. | 12-10-2009 |
20130137715 | Pharmaceutical Compositions Containing A Fluoroquinolone Antibiotic Drug - Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions. | 05-30-2013 |
Inmaculada Castillo Aguilar, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110183364 | ANALYTICAL METHOD FOR THE DETECTION OF LATENT HEPATITIS C, USE THEREOF AND CORRESPONDING DIAGNOSIS KIT - The invention relates to an improved analytical method for the detection of latent hepatitis C, to the use thereof and to the corresponding diagnosis kit. The analytical method is based on the immunoassay technique and the most suitable operating conditions for detecting latent hepatitis C have been determined. The invention also relates to a diagnosis kit complementary to the method. The invention is suitable for use in medicine, biomedical research and in the field of analytical techniques. | 07-28-2011 |
Inmaculada Conejos Sanchez, Betera ES
Patent application number | Description | Published |
---|---|---|
20160114055 | POLYMER DRUG CONJUGATES FOR THE TREATMENT OF AMYLOIDOSIS - The present invention is referred to novel polymeric conjugates to which at least it is linked a fibril disruptor agent and/or a aggregates blocking agent, and additionally a targeting moiety and/or a probe for therapy and diagnosis. | 04-28-2016 |
Inmaculada Conejos Sanchez, Valencia ES
Patent application number | Description | Published |
---|---|---|
20150087788 | Controlled Synthesis of Polyglutamates with Low Polydispersity and Versatile Architectures - Polyglutamates are well known to be highly biocompatible, biodegradable and multifunctional polymers, which have been already used as building blocks in polymer drug conjugates and polymeric micelles. Those systems have been applied to various medical applications ranging from therapy to molecular imaging. Furthermore a polyglutamic acid (PGA) paclitaxel conjugate has already entered clinical studies (Opaxio™ PGA-PTX conjugate currently in phase III of Clinical trials). | 03-26-2015 |
Inmaculada Espigares, Helsinki FI
Patent application number | Description | Published |
---|---|---|
20140087774 | Data Delivery - A method of sending data from a first party participating in a telephone call to a second party participating in the telephone call, comprising, in the terminal of the first party, storing, as a consequence of the telephone call, identifier data that identifies the second party; using the stored identifier data to determine automatically a destination address for a data message; and sending, during the telephone call, the data message with the automatically determined destination address. A method for sending data from a first party participating in a telephone call to a second party participating in the telephone call, comprising, in the terminal of the first party: providing, while the telephone call is on-going, a user selectable option to transfer data to another party participating in the telephone call without user specification of a destination address. | 03-27-2014 |
20150382161 | Data Delivery - A method of sending data from a first party participating in a telephone call to a second party participating in the telephone call, comprising, in the terminal of the first party, storing, as a consequence of the telephone call, identifier data that identifies the second party; using the stored identifier data to determine automatically a destination address for a data message; and sending, during the telephone call, the data message with the automatically determined destination address. A method for sending data from a first party participating in a telephone call to a second party participating in the telephone call, comprising, in the terminal of the first party: providing, while the telephone call is on-going, a user selectable option to transfer data to another party participating in the telephone call without user specification of a destination address. | 12-31-2015 |
Inmaculada Fernández Fernández, Sevilla ES
Patent application number | Description | Published |
---|---|---|
20150110863 | SULFORAPHANE-DERIVED COMPOUNDS, PRODUCTION METHOD THEREOF AND THE MEDICAL, FOOD AND COSMETIC USE OF SAME - The present invention relates to a new series of compounds having general formula (I) and the optical isomer or enantiomer forms thereof, which belong to the family of sulforaphane derivatives. The invention also relates to the production method thereof. The invention further relates to the multiple medical (pharmaceutical, homeopathic and phytotherapeutic), food, cosmetic and dietary uses of said series of compounds, especially the use thereof in the prevention and/or treatment of diseases and any type of illness or damage associated with an oxidative process or which, although not involved in said process, are mediated by the Nrf2 transcription factor, such as, for example, cancer. The compounds can be used alone or, alternatively, encapsulated in cyclodextrins. | 04-23-2015 |
Inmaculada IbÁÑez De CÁceres, Madrid ES
Patent application number | Description | Published |
---|---|---|
20160122828 | METHOD FOR PREDICTING THE RESPONSE TO TREATMENT WITH RADIOTHERAPY COMBINED WITH CHEMOTHERAPY BASED ON CISPLATIN - The invention relates to a method to predict the response to treatment with radiotherapy combined with cisplatin-based chemotherapy in patients with cancer, preferably non-microcytic lung cancer, wherein said method is based on the detection of the presence of methylation in the IGFBP-3 gene. The present invention also relates to an in vitro method to design a customised treatment for an individual with said disease. The method of the invention may be quantitative or semi-quantitative. The present invention also relates to a probe designed for the quantitative detection of the methylation of the IGFBP-3 gene, to a kit that comprises it and to the use of the kit to predict the response of a subject to the aforementioned treatment. | 05-05-2016 |
Inmaculada Lahoz GarcÍa, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20160000022 | BIODEGRADABLE MULCH FOR AGRICULTURAL APPLICATIONS - Biodegradable mulch of the type used in various agricultural applications is made by multi-layer extrusion from a mixture of two compostable biodegradable polymers that comply with the EN13432 standard and that include potato starch, a black masterbatch and biodegradable recycled polymers. The mulch self-degrades in a short period of time, becoming a compostable material that enriches the soil, avoiding the collecting and cleaning tasks that are necessary in conventional mulches. | 01-07-2016 |
Inmaculada Llamas Company, Granada ES
Patent application number | Description | Published |
---|---|---|
20120076829 | ISOLATION, IDENTIFICATION AND CHARACTERISATION OF STRAINS WITH PROBIOTIC ACTIVITY, FROM FAECES OF INFANTS FED EXCLUSIVELY WITH BREAST MILK - The invention relates to probiotic micro-organisms isolated from faeces of children exclusively fed with breast milk. Said microorganisms are used in the food or pharmaceutical industry, especially for use in infant formula milk, due to their probiotic properties which have beneficial effects on the health of those ingesting them. Said microorganisms consist of | 03-29-2012 |
20130280789 | ISOLATION, IDENTIFICATION AND CHARACTERISATION OF STRAINS WITH PROBIOTIC ACTIVITY, FROM FAECES OF INFANTS FED EXCLUSIVELY WITH BREAST MILK - The invention relates to probiotic micro-organisms isolated from feces of children exclusively fed with breast milk. Said microorganisms are used in the food or pharmaceutical industry, especially for use in infant formula milk, due to their probiotic properties which have beneficial effects on the health of those ingesting them. Said microorganisms consist of | 10-24-2013 |
20130280790 | ISOLATION, IDENTIFICATION AND CHARACTERISATION OF STRAINS WITH PROBIOTIC ACTIVITY, FROM FAECES OF INFANTS FED EXCLUSIVELY WITH BREAST MILK - The invention relates to probiotic micro-organisms isolated from faeces of children exclusively fed with breast milk. Said microorganisms are used in the food or pharmaceutical industry, especially for use in infant formula milk, due to their probiotic properties which have beneficial effects on the health of those ingesting them. Said microorganisms consist of | 10-24-2013 |
Inmaculada Mateos-Aparicio Cediel, Madrid ES
Patent application number | Description | Published |
---|---|---|
20150174152 | FAT BINDER OBTAINED FROM BIOMASS RESULTING FROM BEER PRODUCTION - The present invention provides a polysaccharide rich composition comprising beta-glucan, chitin and chitosan, extracted from the cell wall of | 06-25-2015 |
Inmaculada Nadal Gimenez, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100310520 | MICROORGANISMS FOR IMPROVING THE HEALTH OF INDIVIDUALS WITH DISORDERS RELATED TO GLUTEN INGESTION - The invention relates to microorganisms for the treatment of food allergies, specifically coeliac disease, as well as to methods for the selection thereof. The action mechanisms of said microorganisms include: (i) the regulation of the innate and adaptive immunological responses; (ii) the reduction of the concentration of toxic gluten peptide epitopes in the intestinal lumen; (iii) the strengthening of the barrier defence function against harmful antigens and bacteria; and (iv) the provision of enzymatic activities that promote digestion. | 12-09-2010 |
Inmaculada Ratera Bastardas, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110268773 | INCLUSION BODIES, BACTERIAL CELLS AND COMPOSITIONS CONTAINING THEM AND USES THEREOF - The present invention relates to an isolated inclusion body comprising a polypeptide, characterised in that such inclusion body is in particulate form. The present invention also refers to a bacterial cell comprising said inclusion body. The present invention additionally refers to a composition comprising said inclusion body and a eukaryotic cell. The present invention moreover refers to a composition comprising said inclusion body and animal or plant tissue. The present invention furthermore refers to the uses of said inclusion body as medicaments and cell-proliferation stimulators and tissue regenerators. | 11-03-2011 |
Inmaculada Reig Gimeno, Valencia ES
Patent application number | Description | Published |
---|---|---|
20120309872 | BITUMINOUS MATERIAL AND ITS USE FOR THE CONSTRUCTION OF SUB-BALLAST - The present invention relates to a novel bituminous material using vulcanized rubber powder from out-of-use tires, and the use of the same for the construction of sub-ballast. | 12-06-2012 |
Inmaculada Silos-Santiago, Del Mar, CA US
Patent application number | Description | Published |
---|---|---|
20090226449 | Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor - The invention provides isolated nucleic acids molecules, designated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 gene has been introduced or disrupted. The invention still further provides isolated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 proteins, fusion proteins, antigenic peptides and anti-18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 09-10-2009 |
20110165147 | NOVEL 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 AND 26908 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules, designated 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 or 26908 gene has been introduced or disrupted. The invention still further provides isolated 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 or 26908 proteins, fusion proteins, antigenic peptides and anti-18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 or 26908 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 07-07-2011 |
20110171205 | NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules, designated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 15571, 2465, 14266, 2882, 52871, 8203 or 16852 gene has been introduced or disrupted. The invention still further provides isolated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 proteins, fusion proteins, antigenic peptides and anti-15571, 2465, 14266, 2882, 52871, 8203 or 16852 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 07-14-2011 |